Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 Myocarditis and Severity Factors: An Adult Cohort Study

Kun-Long Ma, Zhi-Heng Liu, Chun-Feng Cao, Ming-Ke Liu, Juan Liao, Jing-Bo Zou, Ling-Xi Kong, Ke-Qiang Wan, Jun Zhang, Qun-Bo Wang, Wen-Guang Tian, Guang-Mei Qin, Lei Zhang, Fu-Jun Luan, Shi-Ling Li, Liang-Bo Hu, Qian-Lu Li, View ORCID ProfileHai-Qiang Wang
doi: https://doi.org/10.1101/2020.03.19.20034124
Kun-Long Ma
1Central laboratory, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
2Department of Orthopedics, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi-Heng Liu
3Department of Orthopaedics, Xi’an Air Force 986 Hospital, Air Force Medical University, 172 Youyi Eastern Road, Xi’an 710054, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chun-Feng Cao
1Central laboratory, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
2Department of Orthopedics, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ming-Ke Liu
4Department of Radiology, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Liao
1Central laboratory, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing-Bo Zou
5Yongchuan Center for Disease and Prevention, Huilong Avenue, No. 471, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ling-Xi Kong
6Department of Infectious disease, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ke-Qiang Wan
6Department of Infectious disease, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Zhang
7Baoji Central Hospital, 8 Jiangtan Road, Baoji 721008, Shaanxi Province, P.R. China
8School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an 710061, Shaanxi Province, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qun-Bo Wang
9Management Group of COVID-19, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen-Guang Tian
6Department of Infectious disease, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guang-Mei Qin
10Department of Respiratory Medicine, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lei Zhang
11Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fu-Jun Luan
1Central laboratory, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
2Department of Orthopedics, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shi-Ling Li
12Department of pediatrics, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liang-Bo Hu
4Department of Radiology, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qian-Lu Li
13Department of Neurology, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hai-Qiang Wang
14Institute of Integrative Medicine, Shaanxi University of Chinese Medicine, Xixian Avenue, Xixian District, Xi’an 712046, Shaanxi Province, P.R. China
9Management Group of COVID-19, Yongchuan Hospital of Chongqing Medical University, Xuanhua Road, No. 439, Yongchuan, Chongqing 402160, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hai-Qiang Wang
  • For correspondence: drwanghq@163.com hqwang@sntcm.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Notwithstanding the clinical hallmarks of COVID-19 patients were reported, several critical issues still remain mysterious, i.e., prognostic factors for COVID-19 including extrinsic factors as viral load of SARS-CoV-2 and intrinsic factors as individual’s health conditions; myocarditis incidence rate and hallmarks.

Methods Demographic, epidemiologic, radiologic and laboratory data were collected by medical record reviews of adult hospitalized patients diagnosed as COVID-19. Cycle threshold (Ct) value data of real-time PCR (RT-PCR) were collected. The time duration was from 21 January to 2 March, 2020. Pulmonary inflammation index (PII) values were used for chest CT findings. Multivariate logistic regression analysis was used to identify independent severity risk factors.

RESULTS In total, 84 hospitalized adult patients diagnosed as COVID-19 were included, including 20 severe and 64 nonsevere cases. The viral load of the severe group was significantly higher than that of the non-severe group, regardless of the Ct values for N or ORF1ab gene of virus (all p<0.05).Typical CT abnormalities was more likely existing in the severe group than in the nonsevere group in patchy shadows or ground glass opacities, consolidation, and interlobular septal thickening (all p<0.05). In addition, the PII values in the severe group was significantly higher than that in the nonsevere group (52.5 [42.5-62.5] vs 20 [5.0-31.6]; p<0.001). Amongst 84 patients, 13 patients (15.48%) were noted with abnormal electrocardiograms (ECGs) and serum myocardial enzyme levels; whereas 4 (4.8%) were clinically diagnosed as SARS-CoV-2 myocarditis. Multivariable logistic regress analysis distinguished three key independent risk factors for the severity of COVID-19, including age [OR 2.350; 95% CI (1.206 to 4.580); p=0.012], Ct value [OR 0.158; 95% CI (0.025 to 0.987); p=0.048] and PII [OR 1.912; 95% CI (1.187 to 3.079); p=0.008].

Interpretation Three key-independent risk factors of COVID-19 were identified, including age, PII, and Ct value. The Ct value is closely correlated with the severity of COVID-19, and may act as a predictor of clinical severity of COVID-19 in the early stage. SARS-CoV-2 myocarditis should be highlighted despite a relatively low incidence rate (4.8%). The oxygen pressure and blood oxygen saturation should not be neglected as closely linked with the altitude of epidemic regions.

Evidence before this study We searched Pubmed on March 15, 2020 using the terms (“COVID-19” OR “novel coronavirus” OR “2019 novel coronavirus” OR “2019-nCoV” OR “pneumonia” OR “coronavirus”), AND “Myocarditis” OR “Cycle threshold (Ct)” OR “Altitude”. We found that one article analyzed the risk factors affecting the prognosis of adult patients with COVID-19 in terms of survivorship, without considering Ct values as extrinsic factors. Moreover, there are no reported studies on viral myocarditis caused by COVID-19 and the relationship between the altitude and COVID-19.

Added value of this study We retrospectively analyzed the clinical data, Ct values, laboratory indicators and imaging findings of 84 adult patients with confirmed COVID-19. Three key-independent risk factors of COVID-19 were identified in our study, including age [OR 2.350; 95% CI (1.206 to 4.580); p=0.012], Ct value [OR 0.158; 95% CI (0.025 to 0.987); p=0.048] and PII [OR 1.912; 95% CI (1.187 to 3.079); p=0.008]. Amongst 84 patients, 13 patients (15.48%) were noted with abnormal electrocardiograms (ECGs) and serum myocardial enzyme levels; whereas 4 (4.8%) were clinically diagnosed as SARS-CoV-2 myocarditis. Moreover, altitude should be considered for COVID-19 severity classification, given that oxygen partial pressure and blood oxygen saturation of regional patients vary with altitudes.

Implications of all the available evidence Three key-independent risk factors of COVID-19 were identified, including age, PII, and Ct value. The Ct value is closely correlated with the severity of COVID-19, and may act as a predictor of clinical severity of COVID-19 in the early stage. SARS-CoV-2 myocarditis should be highlighted despite a relatively low incidence rate (4.8%). The oxygen pressure and blood oxygen saturation should not be neglected as closely linked with the altitude of epidemic regions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding was received for the study.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The datasets used to support the current study are available from the authors upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 23, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 Myocarditis and Severity Factors: An Adult Cohort Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 Myocarditis and Severity Factors: An Adult Cohort Study
Kun-Long Ma, Zhi-Heng Liu, Chun-Feng Cao, Ming-Ke Liu, Juan Liao, Jing-Bo Zou, Ling-Xi Kong, Ke-Qiang Wan, Jun Zhang, Qun-Bo Wang, Wen-Guang Tian, Guang-Mei Qin, Lei Zhang, Fu-Jun Luan, Shi-Ling Li, Liang-Bo Hu, Qian-Lu Li, Hai-Qiang Wang
medRxiv 2020.03.19.20034124; doi: https://doi.org/10.1101/2020.03.19.20034124
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 Myocarditis and Severity Factors: An Adult Cohort Study
Kun-Long Ma, Zhi-Heng Liu, Chun-Feng Cao, Ming-Ke Liu, Juan Liao, Jing-Bo Zou, Ling-Xi Kong, Ke-Qiang Wan, Jun Zhang, Qun-Bo Wang, Wen-Guang Tian, Guang-Mei Qin, Lei Zhang, Fu-Jun Luan, Shi-Ling Li, Liang-Bo Hu, Qian-Lu Li, Hai-Qiang Wang
medRxiv 2020.03.19.20034124; doi: https://doi.org/10.1101/2020.03.19.20034124

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (164)
  • Allergy and Immunology (416)
  • Anesthesia (92)
  • Cardiovascular Medicine (867)
  • Dentistry and Oral Medicine (159)
  • Dermatology (98)
  • Emergency Medicine (251)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (397)
  • Epidemiology (8589)
  • Forensic Medicine (4)
  • Gastroenterology (390)
  • Genetic and Genomic Medicine (1772)
  • Geriatric Medicine (169)
  • Health Economics (375)
  • Health Informatics (1252)
  • Health Policy (625)
  • Health Systems and Quality Improvement (472)
  • Hematology (197)
  • HIV/AIDS (380)
  • Infectious Diseases (except HIV/AIDS) (10344)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (193)
  • Medical Ethics (51)
  • Nephrology (214)
  • Neurology (1692)
  • Nursing (97)
  • Nutrition (252)
  • Obstetrics and Gynecology (330)
  • Occupational and Environmental Health (451)
  • Oncology (933)
  • Ophthalmology (265)
  • Orthopedics (104)
  • Otolaryngology (172)
  • Pain Medicine (115)
  • Palliative Medicine (40)
  • Pathology (255)
  • Pediatrics (539)
  • Pharmacology and Therapeutics (257)
  • Primary Care Research (210)
  • Psychiatry and Clinical Psychology (1785)
  • Public and Global Health (3871)
  • Radiology and Imaging (627)
  • Rehabilitation Medicine and Physical Therapy (322)
  • Respiratory Medicine (525)
  • Rheumatology (208)
  • Sexual and Reproductive Health (170)
  • Sports Medicine (158)
  • Surgery (191)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)